comparemela.com

Latest Breaking News On - Tara nath pokhrel - Page 1 : comparemela.com

Who Gets Vaccinated in a Measles-Rubella Campaign in Nepal?: Results from a Post-Campaign Coverage Survey

Who Gets Vaccinated in a Measles-Rubella Campaign in Nepal?: Results from a Post-Campaign Coverage Survey
comminit.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from comminit.com Daily Mail and Mail on Sunday newspapers.

Nepal likely to receive 1 5 million doses of J&J jab from COVAX

Nepal likely to receive 1.5 million doses of J&J jab from COVAX Kathmandu Post Kathmandu, July 6 If everything goes as planned, Nepal is most likely to get 1.5 million doses of the Johnson & Johnson Covid-19 vaccine next week under the COVAX facility, multiple officials at the Ministry of Health and Population confirmed. COVAX, the international vaccine-sharing scheme backed by the United Nations, which has committed to providing 13 million doses of Covid-19 vaccine, sufficient to inoculate 20 percent of the 30 million population, has proposed the authorities to accept the single-shot Johnson & Johnson vaccine. © Rojan Shrestha/NurPhoto A health worker inoculates a dose of the Vero cell COVID-19 vaccine in Bhaktapur, Nepal on Tuesday, June 8, 2021. After receiving 1 million doses of the COVID-19 vaccine from china, the Nepal government has continued vaccination for the 60-64 age groups. (Photo by Rojan Shrestha/NurPhoto via Getty Images)

Problems at biggest vaccine maker leave world short on Covid shots | India News

Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programs as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India. The world’s largest vaccine maker, Serum was last year named a top supplier of Covid shots to Covax, the World Health Organization-backed initiative aimed at securing an equitable global rollout. But the Indian company has been dogged by setbacks, from a ban on exports to a factory fire, that have hampered its ability to fill orders. Covax has pledged to send shots to some 92 countries, but has so far received only 30 million of the minimum 200 million doses it ordered from Serum, which was to provide the bulk of its early supply. Serum’s travails have now become a key illustration of how the effort to inoculate against Covid has failed the developing world and a cautionary tale for becoming over-reliant on one manufacturer

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.